Matches in Wikidata for { <http://www.wikidata.org/entity/Q99560354> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q99560354 description "artículu científicu espublizáu en setiembre de 2020" @default.
- Q99560354 description "scientific article published on 17 September 2020" @default.
- Q99560354 description "wetenschappelijk artikel" @default.
- Q99560354 description "наукова стаття, опублікована 17 вересня 2020" @default.
- Q99560354 name "Promise and Potential Peril with Lumacaftor for the Trafficking Defective Type 2 Long QT Syndrome-Causative Variants, p.G604S, p.N633S, and p.R685P, Using Patient-Specific Re-Engineered Cardiomyocytes" @default.
- Q99560354 name "Promise and Potential Peril with Lumacaftor for the Trafficking Defective Type 2 Long QT Syndrome-Causative Variants, p.G604S, p.N633S, and p.R685P, Using Patient-Specific Re-Engineered Cardiomyocytes" @default.
- Q99560354 type Item @default.
- Q99560354 label "Promise and Potential Peril with Lumacaftor for the Trafficking Defective Type 2 Long QT Syndrome-Causative Variants, p.G604S, p.N633S, and p.R685P, Using Patient-Specific Re-Engineered Cardiomyocytes" @default.
- Q99560354 label "Promise and Potential Peril with Lumacaftor for the Trafficking Defective Type 2 Long QT Syndrome-Causative Variants, p.G604S, p.N633S, and p.R685P, Using Patient-Specific Re-Engineered Cardiomyocytes" @default.
- Q99560354 prefLabel "Promise and Potential Peril with Lumacaftor for the Trafficking Defective Type 2 Long QT Syndrome-Causative Variants, p.G604S, p.N633S, and p.R685P, Using Patient-Specific Re-Engineered Cardiomyocytes" @default.
- Q99560354 prefLabel "Promise and Potential Peril with Lumacaftor for the Trafficking Defective Type 2 Long QT Syndrome-Causative Variants, p.G604S, p.N633S, and p.R685P, Using Patient-Specific Re-Engineered Cardiomyocytes" @default.
- Q99560354 P1433 Q99560354-E100B951-9CFA-47D2-AC48-E530DD18DE10 @default.
- Q99560354 P1476 Q99560354-F8C430BA-4A5F-4E35-AF7F-CC26B7BD2EC0 @default.
- Q99560354 P2093 Q99560354-2AA31334-3A90-45DC-9BE4-BB596A24E3C9 @default.
- Q99560354 P2093 Q99560354-5A89FAE8-E60F-4ECE-B873-B02E8CAA4C39 @default.
- Q99560354 P2093 Q99560354-5C087EEF-9EEA-4064-A6F3-8660D9B2376B @default.
- Q99560354 P2093 Q99560354-9397A181-9352-41B6-8677-37CFC80CA6A5 @default.
- Q99560354 P2093 Q99560354-B209CF0D-DCF8-4186-AD89-E2860D184489 @default.
- Q99560354 P2093 Q99560354-CD252D88-2A28-46E1-BCC0-82C64798A0E2 @default.
- Q99560354 P2860 Q99560354-CB2A9ABD-37CF-403C-A801-84A96B3F27F5 @default.
- Q99560354 P31 Q99560354-8EA95072-E661-4C04-8B90-9100CE0BC558 @default.
- Q99560354 P356 Q99560354-98F9D8E1-14D6-499F-842F-755BBEE106A9 @default.
- Q99560354 P577 Q99560354-D2D8AB92-BFA1-4E5D-9426-7730E2E1206B @default.
- Q99560354 P698 Q99560354-52A879D5-B43A-469C-A1F3-B11ACB06E65D @default.
- Q99560354 P356 CIRCGEN.120.002950 @default.
- Q99560354 P698 32940533 @default.
- Q99560354 P1433 Q96320283 @default.
- Q99560354 P1476 "Promise and Potential Peril with Lumacaftor for the Trafficking Defective Type 2 Long QT Syndrome-Causative Variants, p.G604S, p.N633S, and p.R685P, Using Patient-Specific Re-Engineered Cardiomyocytes" @default.
- Q99560354 P2093 "Bailey J O'Hare" @default.
- Q99560354 P2093 "Cs John Kim" @default.
- Q99560354 P2093 "Dan Ye" @default.
- Q99560354 P2093 "David J Tester" @default.
- Q99560354 P2093 "Michael J Ackerman" @default.
- Q99560354 P2093 "Samantha K Hamrick" @default.
- Q99560354 P2860 Q29620353 @default.
- Q99560354 P31 Q13442814 @default.
- Q99560354 P356 "10.1161/CIRCGEN.120.002950" @default.
- Q99560354 P577 "2020-09-17T00:00:00Z" @default.
- Q99560354 P698 "32940533" @default.